The plaintiff's claim against the defendants is dismissed in entirety.

Litigation costs shall be borne by the plaintiff.

1. Basic facts

A. The relationship between the parties (1) The Plaintiff is a stock company with the purpose of wholesale and retail business of medical devices (the trade name before the change is a stock company E) and its wife, and children’s shares are divided and owned, and F is a company actually operated by F. Defendant B was registered as the representative director of the Plaintiff Company on October 13, 2015, and was registered as the retirement registration at the expiration of the term on October 13, 2018.

(2) From March 23, 2012, Defendant C was registered as an internal director of G Co., Ltd. for the purpose of manufacturing and selling diagnostic reagents. At the same time, Defendant C, along with Defendant B, was registered as an internal director of the Plaintiff Co., Ltd. on October 13, 2015.

(3) Defendant D is a company engaged in the same kind of business as the Plaintiff, which aims at selling medical supplies.

B. Around December 1, 2015, the Plaintiff entered into an agency contract under which G Co., Ltd. can receive and sell goods, and the term of the contract was as follows.

The term of this contract shall be from December 1, 2015 to November 30, 2016.

Unless there is a written declaration of opposition 30 days prior to the expiration of the contract, the contract period shall be automatically extended on a yearly basis.

either party may terminate this contract in the middle of one month prior to the date of entry into force, by giving written notice to the other party.

The Plaintiff is not entitled to any claim against G Co., Ltd. on any ground of the termination or extension of the term of this contract.

C. The above agency contract between the Plaintiff and G Co., Ltd. was maintained for three years until November 30, 2018 following renewal. On October 2018, G Co., Ltd concluded an agency contract with Defendant D Co., Ltd. and subsequently, notified the Plaintiff Company of its intention to refuse renewal.

Since then, the diagnosis reagents, etc. manufactured by G Co., Ltd. are now involved in the Plaintiff’s existing business through Defendant D who newly entered into an agency contract.